Table 1 Patient characteristics (N = 621)

Age

30.1 (7.3; 18–59)

Male (%)

478 (77%)

Education

Primary school

39 (6%)

Secondary school/high school

322 (52%)

Vocational education

150 (24%)

Vocational higher education

65 (11%)

University

45 (7%)

Illness duration (years)

7.3 (4.1; 2.0-43.1)

Age of onset first psychosis (years)

22.3 (6.7; 5–51)

Primary diagnosis

Schizophrenia

398 (64%)

Schizoaffective disorder

80 (13%)

Schizophreniform disorder

37 (6%)

Delusional disorder

14 (2%)

Brief psychotic disorder

13 (2%)

Psychotic disorder NOS

64 (10%)

Other psychotic disorder

15 (2%)

Antidepressants^a

81 (17%)

Antipsychotics^a

No antipsychotics

67 (14%)

Risperidone

58 (12%)

Olanzapine

91 (19%)

Quetiapine

28 (6%)

Clozapine

71 (15%)

Haloperidol

16 (3%)

Aripiprazol

50 (10%)

Other antipsychotics

35 (7%)

Combination therapy

65 (14%)

QIDS-SR₁₆ (total)

6.6 (4.9; 0–26)

CDSS (total)

2.0 (2.8; 1–16)

PANSS Total

61.8 (18.9; 41–148)

PANSS-EMO (emotional distress)

13.1 (4.8; 8–33)

PANSS-NEG (negative symptoms)

12.6 (5.4; 4–41)

PANSS-POS (positive symptoms)

11.3 (5.4; 3–39)

PANSS-DIS (disorganized symptoms)

14.2 (5.1; 10–46)

PANSS-EXC (excitement symptoms)

10.6 (3.2; 2–29)

AIMS (total)

0.1 (0.2; 0–1.9)

BARS (total)

0.3 (0.6; 0–4.0)

UPDRS (subtotal motor symptoms)^b

0.2 (0.1; 0–1.4)